Effect of Sodium-Glucose Co-Transporter-2 Inhibitor on Estimated Plasma Volume in a Patient With Heart Failure With Reduced Ejection Fraction and a Patient With Heart Failure With Preserved Ejection Fraction.
Andreasová TaťánaFilip MálekPublished in: Clinical cardiology (2024)
The early effect of SGLT2i on ePV in patients with heart failure may be monitored by biomarkers of hemoconcentration.